Sagentia Innovation vs Jabil Healthcare: full comparison for 2026
Quick verdict
Sagentia Innovation (4.1/5) edges ahead of Jabil Healthcare (3.8/5) overall. Sagentia Innovation is the better choice for surgical robotics and combination products. Jabil Healthcare is the stronger option for global production capacity for cleared devices. The right choice depends on your project size, budget, and required tech stack.
Sagentia Innovation vs Jabil Healthcare: head-to-head summary
| Criterion | Sagentia Innovation | Jabil Healthcare |
|---|---|---|
| Founded | 1986 | 1966 |
| HQ | Harston, Cambridge, UK | St. Petersburg, FL, USA |
| Team size | 650+ (Science Group) | ~20,000 (healthcare) |
| Rating | 4.1 / 5 | 3.8 / 5 |
| Primary differentiator | Medical development backed by a listed science group that also runs a regulatory consultancy | Global scale, supply chain and FDA-registered production for established medical device brands |
| Pricing model | Time and materials, fixed project | Manufacturing supply agreement, NPI contract |
| Min. engagement | Not disclosed | Not disclosed |
| Primary tech stack | Embedded C/C++, Robotics, Mechanical simulation | Injection molding, Automated assembly, PCB assembly |
| Industries served | Surgical & robotics, Drug delivery, Diagnostics & lab devices | Surgical & robotics, Drug delivery, Wearables & remote monitoring, Consumer health |
Sagentia Innovation vs Jabil Healthcare: overview
Sagentia Innovation
Sagentia Innovation is owned by Science Group plc, which is listed on the London Stock Exchange's AIM market. Its roots go back to 1986; the current business was formed in 2021 from Sagentia, OTM Consulting and Oakland Innovation. It is based at Harston Mill near Cambridge, with R&D facilities in Cambridge and Epsom, and its medical work covers devices, combination products and surgical robotics. Science Group employs more than 650 people across all its businesses.
Jabil Healthcare
Jabil Healthcare was formed in 2020 when Jabil combined its Nypro business with its orthopedics, spine and trauma units. At launch it had nearly 20,000 employees and more than 35 sites, and its factories producing finished medical devices are FDA registered. It covers minimally invasive devices, surgical robotics, complex catheters, diabetes care and consumer health, and the acquisition of CDMO Pii extended it into drug development and aseptic fill-finish. Jabil reported $8.3 billion in company-wide revenue for its second fiscal quarter of 2026.
Services and capabilities: Sagentia Innovation vs Jabil Healthcare
| Capability | Sagentia Innovation | Jabil Healthcare |
|---|---|---|
| Electronics & PCB design | ✓ | ✓ |
| Firmware & embedded software | ✓ | ✗ |
| SaMD & companion apps | ✗ | ✗ |
| Connected devices & IoT | ✗ | ✗ |
| Industrial design & human factors | ✗ | ✗ |
| Mechanical engineering | ✓ | ✓ |
| Device cybersecurity | ✗ | ✗ |
| Regulatory & QMS support | ✓ | ✓ |
| Manufacturing & scale-up | ✗ | ✓ |
Tech stack comparison: Sagentia Innovation vs Jabil Healthcare
| Framework / platform | Sagentia Innovation | Jabil Healthcare |
|---|---|---|
| Embedded C/C++ | ✓ | N/A |
| Embedded Linux | N/A | N/A |
| RTOS | N/A | N/A |
| BLE | N/A | N/A |
| Cloud (AWS/Azure) | N/A | N/A |
| IEC 62304 | N/A | N/A |
| ISO 14971 | N/A | N/A |
| ISO 13485 QMS | ✓ | ✓ |
| Qt | N/A | N/A |
Pricing comparison: Sagentia Innovation vs Jabil Healthcare
| Criterion | Sagentia Innovation | Jabil Healthcare |
|---|---|---|
| Minimum engagement | Not disclosed | Not disclosed |
| Engagement models | Consulting, Fixed project, Time & materials | Manufacturing contract |
| Rate transparency | Not public | Not public |
| Price tier | Mid-market | Mid-market |
Target audience comparison: Sagentia Innovation vs Jabil Healthcare
| Dimension | Sagentia Innovation | Jabil Healthcare |
|---|---|---|
| Best company size | Startup to mid-market | Startup to mid-market |
| Best industries | Surgical & robotics, Drug delivery, Diagnostics & lab devices | Surgical & robotics, Drug delivery, Wearables & remote monitoring |
| Best use cases | Surgical robot subsystem development, Drug-device combination product engineering | Scaling production of a cleared diabetes device, Global manufacturing of a surgical robotics subsystem |
| Typical project type | Consulting | Manufacturing contract |
Sagentia Innovation vs Jabil Healthcare: pros and cons
| Sagentia Innovation | |
|---|---|
| + | Active surgical robotics software and hardware hiring shows current work in that area |
| + | Sister business TSG Consulting has a medical device regulatory team |
| + | Large owned R&D facilities in Cambridge and Epsom |
| + | About 30 years of medical device projects |
| - | Part of a listed group, so commercial priorities answer to public shareholders |
| - | Recent 2021 merger means the brand and teams are relatively new |
| - | Science Group headcount covers many businesses, so the medtech team size is unclear |
| Jabil Healthcare | |
|---|---|
| + | One of the largest healthcare manufacturing networks in the world |
| + | FDA-registered sites for finished devices |
| + | Strong supply chain management during component shortages |
| + | Covers drug delivery through the Pii acquisition |
| - | Built for production volume; early design and invention are outside its main business |
| - | Small companies may struggle to get attention |
| - | Engineering support is tied to manufacturing programs |
Who should choose Sagentia Innovation?
A typical fit: surgical robot subsystem development.
Medical development backed by a listed science group that also runs a regulatory consultancy. Minimum engagement is not publicly disclosed. Works best with clients in Surgical & robotics, Drug delivery, Diagnostics & lab devices.
Who should choose Jabil Healthcare?
A typical fit: scaling production of a cleared diabetes device.
Global scale, supply chain and FDA-registered production for established medical device brands. Minimum engagement is not publicly disclosed. Works best with clients in Surgical & robotics, Drug delivery, Wearables & remote monitoring, Consumer health.
Decision matrix: Sagentia Innovation vs Jabil Healthcare
| Your situation | Recommended choice |
|---|---|
| You need full-ownership delivery on a defined project scope | Sagentia Innovation |
| You need a large dedicated team for an ongoing programme | Check each company's engagement model |
| Your budget is at the lower end | Compare: Sagentia Innovation (Not disclosed) vs Jabil Healthcare (Not disclosed) |
| You need specialist depth in a specific vertical | Jabil Healthcare |
| You need staff augmentation or team extension | Neither; consider alternatives that offer staff aug |
| You need consulting before committing to a build | Both may offer discovery engagements |
Use case fit: Sagentia Innovation vs Jabil Healthcare
| Use case | Sagentia Innovation fit | Jabil Healthcare fit | Winner |
|---|---|---|---|
| Surgical robot subsystem development | Strong | Strong | Both equally |
| Drug-device combination product engineering | Strong | Limited | Sagentia Innovation |
| Scaling production of a cleared diabetes device | Limited | Strong | Jabil Healthcare |
| Global manufacturing of a surgical robotics subsystem | Limited | Strong | Jabil Healthcare |
Verdict: Sagentia Innovation vs Jabil Healthcare
Sagentia Innovation (4.1/5) is the stronger overall choice for most Medical Device Development projects. Medical development backed by a listed science group that also runs a regulatory consultancy.
Jabil Healthcare (3.8/5) is worth a look if you need global manufacturing of a surgical robotics subsystem. If your situation matches that, Jabil Healthcare is a competitive option.
Related comparisons
Sagentia Innovation vs Jabil Healthcare FAQ
Is Sagentia Innovation better than Jabil Healthcare?
Sagentia Innovation (4.1/5) scores higher overall, but "better" depends on your use case. Sagentia Innovation's strongest advantage: active surgical robotics software and hardware hiring shows current work in that area. Jabil Healthcare's strongest advantage: one of the largest healthcare manufacturing networks in the world.
How do Sagentia Innovation and Jabil Healthcare differ in pricing?
Sagentia Innovation uses time and materials, fixed project pricing. Jabil Healthcare uses manufacturing supply agreement, npi contract pricing. Neither firm publishes a full rate card; a discovery call is required for project-specific quotes.
Which is better for enterprise: Sagentia Innovation or Jabil Healthcare?
Jabil Healthcare is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each company before shortlisting.
What are the main differences between Sagentia Innovation and Jabil Healthcare?
Sagentia Innovation's primary differentiator is: medical development backed by a listed science group that also runs a regulatory consultancy. Jabil Healthcare's primary differentiator is: global scale, supply chain and FDA-registered production for established medical device brands. They also differ in team size (650+ (Science Group) vs ~20,000 (healthcare)), minimum engagement (Not disclosed vs Not disclosed), and primary industries served (Surgical & robotics, Drug delivery vs Surgical & robotics, Drug delivery).
Verify all details directly with each company before making a decision.